Related Experiment Video
Updated: Aug 23, 2025

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Non-Transfusion-Dependent Thalassemia: A Panoramic Review
Hwazen Shash1,2
1College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.
Non-transfusion-dependent thalassemia (NTDT) patients face significant complications despite not needing transfusions. Early diagnosis and intervention are crucial for managing NTDT effectively.
Area of Science:
- Hematology
- Genetics
- Internal Medicine
Background:
- Non-transfusion-dependent thalassemia (NTDT) is often perceived as less severe than transfusion-dependent forms.
- Common NTDT types include beta-thalassemia intermedia, hemoglobin E/beta thalassemia, and hemoglobin H disease.
- NTDT patients experience clinical complications despite transfusion independence.
Purpose of the Study:
- To enhance clinician awareness of NTDT.
- To review NTDT definition, genetics, pathophysiology, and complications.
- To outline management options and recent therapeutic advancements.
Main Methods:
- Literature review focusing on NTDT.
- Analysis of pathophysiology, including ineffective erythropoiesis, iron overload, and hypercoagulability.
- Examination of clinical complications and risk factors.
Main Results:
- NTDT patients are susceptible to serious morbidities.
- Ineffective erythropoiesis, iron overload, and hypercoagulability are key pathophysiological drivers.
- Early diagnosis is vital for timely intervention.
Conclusions:
- NTDT requires comprehensive management beyond transfusion status.
- Understanding NTDT pathophysiology informs therapeutic strategies.
- Ongoing research and novel therapies are advancing NTDT care.
More Related Videos
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Related Concept Videos
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...